tiprankstipranks
Advertisement
Advertisement

INKT Stock Latest News

Buy Rating on MiNK Therapeutics Driven by Promising Phase 2 Survival Benefit and Immune Activation in PD-1–Refractory Gastric Cancer
RatingsBuy Rating on MiNK Therapeutics Driven by Promising Phase 2 Survival Benefit and Immune Activation in PD-1–Refractory Gastric Cancer
7d ago
INKT
MiNK Therapeutics management to meet virtually with B. Riley
PremiumThe Fly
MiNK Therapeutics management to meet virtually with B. Riley
10d ago
INKT
MiNK Therapeutics: Buy Rating on Emerging Pulmonary Franchise and Key agenT-797 ARDS Catalyst
PremiumRatings
MiNK Therapeutics: Buy Rating on Emerging Pulmonary Franchise and Key agenT-797 ARDS Catalyst
29d ago
INKT
MiNK Therapeutics’ Earnings Call Signals High-Risk Upside
PremiumCompany Announcements
MiNK Therapeutics’ Earnings Call Signals High-Risk Upside
30d ago
INKT
INKT Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
INKT Upcoming Earnings Report: What to Expect?
1M ago
INKT
MiNK Therapeutics Explores Strategic Partnerships and Trial Collaborations
PremiumCompany AnnouncementsMiNK Therapeutics Explores Strategic Partnerships and Trial Collaborations
1M ago
8K
INKT
MiNK Therapeutics Appoints New Principal Financial and Accounting Officers
Premium
Company Announcements
MiNK Therapeutics Appoints New Principal Financial and Accounting Officers
1M ago
8K
INKT
3 Penny Stocks to Watch Now, 3/11/26
Premium
Market News
3 Penny Stocks to Watch Now, 3/11/26
2M ago
ATPC
INKT
Morning News Wrap-Up 3/10/26: Tuesday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up 3/10/26: Tuesday’s Biggest Stock Market Stories!
2M ago
GD
AMD
MiNK Therapeutics: Buy Rating Backed by Non-Dilutive PRAME iNKT Partnership and Expanded Oncology Upside
PremiumRatings
MiNK Therapeutics: Buy Rating Backed by Non-Dilutive PRAME iNKT Partnership and Expanded Oncology Upside
2M ago
INKT
Why Is MiNK Therapeutics Stock (INKT) Up Today?
PremiumMarket News
Why Is MiNK Therapeutics Stock (INKT) Up Today?
2M ago
INKT
MiNK Therapeutics announces strategic collaboration with C-Further
PremiumThe Fly
MiNK Therapeutics announces strategic collaboration with C-Further
2M ago
INKT
MiNK Therapeutics announces new invariant natural killer T cells data
PremiumThe FlyMiNK Therapeutics announces new invariant natural killer T cells data
3M ago
INKT
MiNK, University of Wisconsin-Madison announce Phase 1 agenT-797 trial
Premium
The Fly
MiNK, University of Wisconsin-Madison announce Phase 1 agenT-797 trial
4M ago
INKT
MiNK Therapeutics announces board resignation amid public appointment
Premium
Company Announcements
MiNK Therapeutics announces board resignation amid public appointment
4M ago
8K
INKT
MiNK Therapeutics announces publication of new preclinical data for MiNK-215
PremiumThe Fly
MiNK Therapeutics announces publication of new preclinical data for MiNK-215
5M ago
INKT
MiNK Therapeutics Advances iNKT Platform in Q3 2025
PremiumCompany Announcements
MiNK Therapeutics Advances iNKT Platform in Q3 2025
6M ago
INKT
MiNK Therapeutics Earnings Call: Positive Sentiment and Promising Future
PremiumCompany Announcements
MiNK Therapeutics Earnings Call: Positive Sentiment and Promising Future
6M ago
INKT
MiNK Therapeutics: Advancing Clinical Trials and Strategic Partnerships to Address GvHD and Pulmonary Diseases
PremiumRatings
MiNK Therapeutics: Advancing Clinical Trials and Strategic Partnerships to Address GvHD and Pulmonary Diseases
6M ago
INKT
MiNK Therapeutics reports Q3 EPS (65c) vs (46c) last year
PremiumThe FlyMiNK Therapeutics reports Q3 EPS (65c) vs (46c) last year
6M ago
INKT
INKT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
INKT Upcoming Earnings Report: What to Expect?
6M ago
INKT
MiNK Therapeutics files $150M mixed securities shelf
Premium
The Fly
MiNK Therapeutics files $150M mixed securities shelf
6M ago
INKT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >